0001328143-21-000059.txt : 20210604 0001328143-21-000059.hdr.sgml : 20210604 20210604161541 ACCESSION NUMBER: 0001328143-21-000059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210602 FILED AS OF DATE: 20210604 DATE AS OF CHANGE: 20210604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAHONEY DAVID L CENTRAL INDEX KEY: 0001224091 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 21996640 MAIL ADDRESS: STREET 1: SYMANTEC CORPORATION STREET 2: 20330 STEVENS CREEK BLVD. CITY: CUPERTINO STATE: CA ZIP: 95014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 1000 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 1000 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 4 1 wf-form4_162283772332268.xml FORM 4 X0306 4 2021-06-02 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001224091 MAHONEY DAVID L C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2021-06-02 4 A 0 5000 0 A 115153 D Common Stock 2628 I David L. Mahoney & Winnifred C. Ellis 1998 Family Trust Stock Option (Right to Buy) 5.21 2021-06-02 4 A 0 10000 0 A 2022-06-02 2031-06-01 Common Stock 10000.0 10000 D The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest on the one year anniversary of the grant date, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date. The Option shares vest in full on the one year anniversary of the grant date, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date. /s/ Christopher B. Prentiss, Attorney-in-fact 2021-06-04